Increased prevalence of Toxoplasma gondii seropositivity in patients with treatment-resistant schizophrenia

Schizophr Res. 2018 Mar:193:480-481. doi: 10.1016/j.schres.2017.08.006. Epub 2017 Aug 9.

¹ Clinics for Psychiatry Vrapce, Zagreb, Croatia.
² School of Medicine, University of Zagreb, Zagreb, Croatia; Clinical Hospital Centre Zagreb, Department of Psychiatry, Zagreb, Croatia. Electronic address: marinasagud@mail.com.
³ Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia. Electronic address: dsvob@irb.hr.
⁴ School of Medicine, University of Zagreb, Zagreb, Croatia; Microbiology Service, Croatian National Institute of Public Health, Zagreb, Croatia.
⁵ Clinical Hospital Centre Zagreb, Department of Psychiatry, Zagreb, Croatia; School of Medicine, University of Osijek, Osijek, Croatia; School of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina.
⁶ School of Medicine, University of Zagreb, Zagreb, Croatia; Clinical Hospital Centre Zagreb, Department of Psychiatry, Zagreb, Croatia.
⁷ Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia.

No abstract available

Keywords: Schizophrenia; Symptom severity; Toxoplasma gondii seropositivity; Treatment-resistant.

Publication types